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Abstract. Chronic obstructive pulmonary disease (COPD) is 
a relatively common disease, affecting mainly males in the 
western world. Although substantial data are available as 
regards the clinicopathological characterization of COPD, 
little is known of the molecular basis of the disease. In the 
present study we analysed the incidence of microsatellite 
instability (MI) in cytological specimens from patients with 
COPD. MI reflects increased mutational rate and is 
associated with decreased accuracy in the DNA repair, 
resulting in the accumulation of somatic mutations in cells 
manifesting this genetic alteration. Among 31 specimens 
tested, 7 (23%) exhibited MI in at least one among 6 
microsatellite markers tested. 5 cases were affected in only 
one marker while the remaining two cases exhibited evidence 
of MI in two microsatellite markers. These data suggest that 
an elevated mutational rate as reflected by the increased 
incidence of MI is associated with the development of the 
disease. 
Introduction 
Chronic obstructive pulmonary disease (COPD) is a disorder 
characterised by reduced maximum expiratory flow and 
slow forced emptying of the lungs: features which do not 
change markedly over several months. Most of the airflow 
limitation is due to varying combinations of airway disease 
and emphysema. It is difficult to define in vivo the relative 
contribution of the two processes (1,2). 
The two major diseases classified as COPD are 
emphysema and chronic bronchitis. Both are histologically 
characterised by increased wall thickening, increased 
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intraluminal mucus and changes in the lining fluids of the 
small airways. Emphysema is defined anatomically by 
permanent destructive enlargement of airspaces distal to the 
terminal bronchioles without obvious fibrosis (3). In contrast 
chronic bronchitis is defined by the presence of chronic or 
recurrent increases in bronchial secretions sufficient to cause 
expectoration. This hypersecretion can occur in the absence 
of airflow limitation (4,5). 
It is of interest to note that most of the patients with 
COPD are or were cigarette smokers. The two main 
symptoms that cause patients with COPD to consult a 
physician are breathlessness and cough, sometimes 
accompanied by wheezing or sputum production. A history 
of repeated respiratory infections, especially during the 
winter, is common. Most patients are long-term cigarette 
smokers. 
Although several clinical studies exist on the 
pathophysiology of COPD, little is known as regards the 
molecular basis of the disease. In the present study we 
performed an assessment of the mutational rate in patients 
with COPD, as reflected by the incidence of microsatellite 
instability (6). 
Instability of tandem repeat DNA sequences or MI, is a 
genetic disorder that occurs in many tumours (7-14) and it 
has been correlated with a high mutational rate (15). 
Mutations in genes involved in DNA repair has been 
aetiologically associated with this disorder (16). 
In the present study we distinguished the molecular basis 
of the COPD disease. We investigated the incidence of MI in 
31 patients with COPD and whether this particular alteration 
is detectable in cytological specimens. We found that 7 
(23%) cases exhibited MI suggesting that elevated mutational 
rate is associated with the development of the disease. 
Materials and methods 
Specimens and DNA extraction. Specimens were obtained 
from the University Hospital, Department of Pulmonary 
Medicine, Heraklion, Greece. DNA from the peripheral 
blood was extracted by the Nucléon kit (Scotlab) following 
the manufacturer's instructions. DNA from cytological 
material was extracted by the standard boiling method and 
ethanol precipitation. DNA samples were stored at 4°C. 
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Table I. Incidence of microsatellite instability and chromosomal 
location for the 6 microsatellite markers used. 
D3S1210 
Case No. 
Marker 
D3S1234 
D3S1210 
D6S344 
HRM 
THRA1 
D17S250 
Chromosome 
' 3 
3 
6 
11 
17 
17 
Cases with alteration (%) 
0 
2 (6) 
1 (3) 
2 (6) 
3(10) 
1 (3) 
Table II. Microsatellite instability in patients with COPD. 
Patient D3S1234 THRA1 D6S344 D17S250 HRM D3S1210 
no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
+ - + 
+ 
Microsatellite analysis. Six microsatellite markers located on 
4 different chromosomes were used. PCR reactions were 
performed in a 12.5 μΐ reaction volume containing approx. 
100 ng of genomic DNA, 500 μΜ dNTPs, 10 pmol of each 
forward and reverse primer, 1.25 μΐ of 10X buffer [670 mM 
3 
Ν C 
THRA1 
Case No. 5 8 
N C C Ν 
Figure 1. Representative examples of specimens exhibiting microsatellite 
instability. Ν and C correspond to peripheral blood and cytological 
specimens respectively. 
Tris-HCl pH 8.5, 166 mM ammonium sulphate, 67 mM 
MgCl2, 1.7 mg/ml bovine serum albumin, 100 mM ß-
mercaptoethanol and 1% (w/v) Triton-X-100] and 0.3 U Taq 
polymerase. The reactions were denatured for 5 min at 95°C 
and the DNA was subsequently amplified for 28 cycles at 
95°C, 58-60°C and 72°C each step. 5 μΐ of the PCR product 
was electrophoresed in a 10% Polyacrylamide gel and silver 
stained. MI was scored by comparing the electrophoretic 
pattern of the microsatellite markers amplified from the 
paired DNA preparations that corresponded to the cytological 
specimens and the peripheral blood sample. The analysis in 
the MI positive cases was repeated at least twice and the 
results were highly reproducible. 
Results and Discussion 
Thirty-one cytological specimens from patients with COPD 
were analysed for MI using a bank of 6 polymorphic 
microsatellite markers (Table I). The electrophoretic pattern 
of each specimen was compared with the corresponding 
pattern of the peripheral blood and any difference in the 
mobility of the microsatellite alleles was interpreted as MI. 
Among 31 cases tested, 7 (23%) were interpreted as MI-
positive. In 5 of these cases instability affected only 1 marker 
while in the remaining 2 cases, 2 markers were affected 
(Table II, Fig. 1). 
A methodological limitation of the current analysis is that 
cytological samples have a considerable quantity of normal 
DNA. This results in a competition between the novel 
microsatellite alleles produced by the instability and the 
normal alleles, which might eliminate the signal of the 
mutant alleles. This may decrease the figures of the present 
study since false negative results may be obtained. However, 
23% of the specimens exhibited MI suggesting that this 
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particular alteration is a detectable phenomenon in the 
development of the disease. 
M i c r o s a t e l l i t e ins tab i l i ty ini t ia l ly was d e t e c t e d in 
hereditary non polyposis colorectal cancer and later extended 
to a lmost all human sporadic tumours including lung, 
endometrial, colorectal, head and neck and prostatic tumours 
(7-14). In addition, recent studies suggested that MI is also a 
detectable phenomenon in spontaneously aborted embryonic 
tissues (17-19). MI is the direct result of decreased accuracy 
in DNA repair and replication and it reflects an elevated 
m u t a t i o n a l ra te which i n d i c a t e s des tab i l iza t ion in the 
genome. The detection of MI in patients with COPD suggests 
that the d i s e a s e p r o c e e d s t h r o u g h m u t a t i o n s w h i c h 
consequently activate or inactivate other genes involved in 
the pathogenesis of the disease. However, the potential 
targets of these mutations remain obscure since the molecular 
basis of the disease is unclear as yet. 
An a d d i t i o n a l p o i n t of the p r e s e n t s tudy is that it 
d e m o n s t r a t e s that the d e t e c t i o n of M I is p o s s i b l e in 
cytological material. This may find clinical application in 
pat ients with lung c a n c e r (20,21) s ince the disease is 
characterised by a high incidence of MI and alterations in 
oncogenes and onco-suppressor genes (22). 
The present study suggest that COPD is characterised by 
a considerable incidence of MI and that this part icular 
genomic alteration is detectable in cytological specimens. 
Future studies are required in order to reveal the precise 
significance of these findings and their potential role in the 
clinical practice. 
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